BXP vs. FUM, EAH, SAR, NIOX, MGP, BVXP, TSTL, FARN, ARIX, and CIR
Should you be buying Beximco Pharmaceuticals stock or one of its competitors? The main competitors of Beximco Pharmaceuticals include Futura Medical (FUM), ECO Animal Health Group (EAH), Sareum (SAR), NIOX Group (NIOX), Medica Group (MGP), Bioventix (BVXP), Tristel (TSTL), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), and Circassia Group (CIR). These companies are all part of the "medical" sector.
Beximco Pharmaceuticals vs.
Futura Medical (LON:FUM) and Beximco Pharmaceuticals (LON:BXP) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, valuation and community ranking.
Beximco Pharmaceuticals has a net margin of 12.38% compared to Futura Medical's net margin of 0.00%. Beximco Pharmaceuticals' return on equity of 10.22% beat Futura Medical's return on equity.
In the previous week, Futura Medical's average media sentiment score of 0.00 equaled Beximco Pharmaceuticals' average media sentiment score.
Beximco Pharmaceuticals has lower revenue, but higher earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Beximco Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
34.5% of Futura Medical shares are owned by institutional investors. Comparatively, 1.8% of Beximco Pharmaceuticals shares are owned by institutional investors. 36.0% of Futura Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Futura Medical received 78 more outperform votes than Beximco Pharmaceuticals when rated by MarketBeat users. However, 64.67% of users gave Beximco Pharmaceuticals an outperform vote while only 64.36% of users gave Futura Medical an outperform vote.
Futura Medical has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500. Comparatively, Beximco Pharmaceuticals has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500.
Summary
Beximco Pharmaceuticals beats Futura Medical on 6 of the 11 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beximco Pharmaceuticals Competitors List
